The Valley Desk

NCT04964934 · Interventional trial

Phase III Study to Assess AZD9833+ CDK4/6 Inhibitor in HR+/HER2-MBC With Detectable ESR1m Before Progression (SERENA-6)

Overall registry status Active not recruiting

Phase 3

Conditions ER-Positive HER2-Negative Breast Cancer

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov